Sign in

CIK 0001636282 · Large accelerated filer

Spyre Therapeutics, Inc.

Sign in to watch
Ticker
SYRE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
464312787
Phone
6176515940
Business address
221 CRESCENT STREET, BUILDING 23, SUITE 105, WALTHAM, MA, 02453
Former names
Aeglea BioTherapeutics, Inc.
  1. CORRESP Other Correspondence Between Filers and SEC Staff
  2. PRE 14A Proxy Proxy Statement (Preliminary)
  3. 424B3 Offering Prospectus
  4. 8-K Event Material agreement · Unregistered share sale · Bylaws or fiscal year change · Regulation FD disclosure
  5. CORRESP Other Correspondence Between Filers and SEC Staff
  6. POS AM Other Post-effective Amendment for Registration Statement
  7. S-1/A Offering Registration Statement
  8. SC 13G/A Stake Amended Statement of Ownership
  9. UPLOAD Other SEC-generated Letter
  10. POS AM Other Post-effective Amendment for Registration Statement
  11. CORRESP Other Correspondence Between Filers and SEC Staff
  12. S-1/A Offering Registration Statement
  13. 10-K/A Report 10-K/A
  14. S-8 Other Securities Offered to Employees in Benefit Plans
  15. 8-K Event Results of operations
  16. 10-K Report Annual Report
  17. 4 Insider Changes in Ownership
  18. UPLOAD Other SEC-generated Letter
  19. SC 13G/A Stake Amended Statement of Ownership
  20. SC 13G/A Stake Amended Statement of Ownership

Page 12 of 42 · 823 filings